Abstract: Rosai-Dorfman disease is a benign histiocytic proliferative disorder of unknown etiology. The disease mainly affects lymph node tissue, although it is rarely confined to the skin. Here, we describe a 53-year-old woman with purely cutaneous Rosai-Dorfman disease. The patient presented with a large pigmented plaque on her left leg, and sparse erythematous papules on her face and arms. A complete clinical response was achieved with thalidomide, followed by recurrence at the initial site one year later. The histological examination displayed the typical features of Rosai-Dorfman disease in the recent lesions but not in the older lesions. In the setting of no lymphadenopathy, the histopathological features of Rosai-Dorfman disease are commonly misinterpreted. Therefore, awareness of the histological aspects present at different stages, not always featuring the hallmark microscopic signs of Rosai-Dorfman disease, is particularly important for a correct diagnosis of this rare disorder.
INTRODUCTION
Rosai-Dorfman disease (RDD) is a benign histiocytic proliferative disorder of unknown etiology. Typically, it presents as a painless, bilateral, massive, cervical lymphadenopathy, commonly in association with systemic symptoms, such as fever, weight loss, night sweats, leukocytosis, polyclonal gammopathy and increased erythrocyte sedimentation rate (ESR).
1,2
Although originally described as a nodal disorder, extranodal disease occurs in up to 40% of cases, with skin affected in about 10% of cases. 1, 3, 4 More rarely, cutaneous lesions are the sole manifestation, with purely cutaneous-RDD (CRDD) representing a small minority (3%) of RDD described cases. 1,3,4 CRDD is considered a distinct entity, based on the exclusive involvement of the skin, different demographic features and better prognosis, compared with systemic RDD. 4, 5 As the cutaneous lesions are clinically nonspecific, the diagnosis of CRDD is histological, and essentially relying on the presence of an infiltrate containing large pale histiocytes, commonly displaying emperipolesis, accompanied by lymphocytes and abundant plasma cells. In the setting of no lymphadenopathy, the histopathological features of RDD are commonly misinterpreted, and it is important to consider that histological features vary in correlation with the cutaneous lesions duration.
5,6
CASE REPORT A 53-year-old female presented with a 1 year-history of a poorly circumscribed, erythematous to brown, slightly verrucous, indurated 15cm plaque with superimposed violaceous papules and additional satellite erythematous papules, located on her left leg. The plaque progressed for 1 year, starting as a small, dark area, gradually enlarging (Figure 1 ). In addition, she had sparse domeshaped erythematous papules located on her face and arms, which appeared two months before ( Figure 2 ). The skin lesions were asymptomatic, and the general physical examination was unremarkable, with no lymphadenopathy, organomegaly, or systemic symptoms like fever, malaise or weight loss. Her past medical history included obesity, hypertension and bipolar disorder. The first clinical impression was Kaposi's sarcoma and skin biopsies were taken from her arm and leg.
Histological examination of a papule located on the arm that had evolved for approximately 2 months revealed a dense nodular infiltrate in the dermis, extending focally to the hypodermis. 
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FIgure 1: Hyperpigmented, indurated plaque with superimposed and satellite papules on the left leg RDD may belong to a spectrum of disorders with SLC29A3 mutations, namely H syndrome. 10 The evidence of a germline mutation in SLC29A3 in patients with familial RDD, as well as the finding of emperipolesis in cutaneous lesions of H syndrome would support this hypothesis, but this association has not been demonstrated in the cutaneous forms of the disease.
10,11
The classic clinical features described in CRDD were reproduced in our patient. Systemic RDD is more common in males and in children or young adults of African descent, whereas CRDD predominates in older females, of non-black ancestry. The coexpression by the histiocytic CRDD cells of S-100 protein and monocyte/macrophage markers, such as lysozyme, α1-antitrypsin, CD68 and CD163, the non-reactivity to Langerhans cell markers, including CD1 and langerin, which was also featured in FIgure 6: Diffuse anti-S100 cytoplasmic staining of histocytic population. (S100 stain, original magnification x200) 
